The value of vedolizumab as rescue therapy in moderate-severe Crohn's disease patients with adalimumab non-response in the USA

Erim, DO., Mahendraratnam, N., Okafor, PN., & Wheeler, SB. (2015). The value of vedolizumab as rescue therapy in moderate-severe Crohn's disease patients with adalimumab non-response in the USA. Journal of Crohn's and Colitis. https://doi.org/10.1093/ecco-jcc/jjv090

Download/Explore

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

Multifaceted risk for non-suicidal self-injury only versus suicide attempt in a population-based cohort of adults
Article

Pregnancy rates and clinical outcomes among women living with HIV enrolled in HPTN 052
Article

The influence of mediators on the relationship between antenatal opioid agonist exposure and the severity of neonatal opioid withdrawal syndrome
Article

A scoping review of empirical research on prescription drug promotion